ES3049508T3 - Ropinirole-containing patch and method for improving skin permeability of ropinirole - Google Patents

Ropinirole-containing patch and method for improving skin permeability of ropinirole

Info

Publication number
ES3049508T3
ES3049508T3 ES21886044T ES21886044T ES3049508T3 ES 3049508 T3 ES3049508 T3 ES 3049508T3 ES 21886044 T ES21886044 T ES 21886044T ES 21886044 T ES21886044 T ES 21886044T ES 3049508 T3 ES3049508 T3 ES 3049508T3
Authority
ES
Spain
Prior art keywords
ropinirole
improving skin
skin permeability
containing patch
patch
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES21886044T
Other languages
English (en)
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hisamitsu Pharmaceutical Co Inc
Original Assignee
Hisamitsu Pharmaceutical Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hisamitsu Pharmaceutical Co Inc filed Critical Hisamitsu Pharmaceutical Co Inc
Application granted granted Critical
Publication of ES3049508T3 publication Critical patent/ES3049508T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Psychology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ES21886044T 2020-10-29 2021-10-21 Ropinirole-containing patch and method for improving skin permeability of ropinirole Active ES3049508T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2020181280 2020-10-29
PCT/JP2021/038892 WO2022091925A1 (ja) 2020-10-29 2021-10-21 ロピニロール含有貼付剤及びロピニロールの皮膚透過性向上方法

Publications (1)

Publication Number Publication Date
ES3049508T3 true ES3049508T3 (en) 2025-12-17

Family

ID=81382322

Family Applications (1)

Application Number Title Priority Date Filing Date
ES21886044T Active ES3049508T3 (en) 2020-10-29 2021-10-21 Ropinirole-containing patch and method for improving skin permeability of ropinirole

Country Status (8)

Country Link
US (1) US12440452B2 (enExample)
EP (1) EP4238563B1 (enExample)
JP (1) JP7284877B2 (enExample)
KR (1) KR102577838B1 (enExample)
CN (1) CN116322658B (enExample)
ES (1) ES3049508T3 (enExample)
TW (1) TWI821765B (enExample)
WO (1) WO2022091925A1 (enExample)

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5872111A (en) * 1997-05-19 1999-02-16 Lever Brothers Company, Division Of Conopco, Inc. Compositions comprising glycosylamide surfactants
DE10137162A1 (de) * 2001-07-30 2003-02-20 Hexal Ag Matrixkontrolliertes transdermales therapeutisches System zur Anwendung von Pramiprexol und Ropinirol
JP5485135B2 (ja) 2008-02-27 2014-05-07 久光製薬株式会社 貼付製剤
JP5546013B2 (ja) * 2008-02-27 2014-07-09 久光製薬株式会社 貼付剤及び包装体
WO2010134433A1 (ja) 2009-05-21 2010-11-25 久光製薬株式会社 経皮吸収製剤
JP5631854B2 (ja) * 2010-12-13 2014-11-26 久光製薬株式会社 医薬組成物および貼付剤
ES2657016T3 (es) 2011-05-31 2018-03-01 Hisamitsu Pharmaceutical Co., Inc. Parche cutáneo adhesivo que contiene ropinirol y producto envasado del mismo
US9155710B2 (en) 2011-05-31 2015-10-13 Hisamitsu Pharmaceutical Co., Inc. Ropinirole-containing patch and package thereof
US9849095B2 (en) * 2011-12-01 2017-12-26 Teikoku Seiyaku Co., Ltd. Ropinirole-containing adhesive patch
EP2887962B1 (en) * 2012-08-24 2021-05-26 Integurx Therapeutics LLC Chemical compositions and methods for enhancing transdermal delivery of therapeutic agents
CN106456561B (zh) * 2013-10-07 2020-02-28 帝国制药美国公司 使用右旋美托咪啶经皮组合物治疗注意力缺陷多动症、焦虑症和失眠症的方法和组合物
US10449254B2 (en) * 2013-11-03 2019-10-22 The Regents Of The University Of California Ionic liquids for transdermal drug delivery
JP6373061B2 (ja) * 2014-05-23 2018-08-15 帝國製薬株式会社 経皮投与製剤
WO2017037812A1 (ja) * 2015-08-29 2017-03-09 株式会社メドレックス 酸捕捉剤を含有する貼付製剤
US10392371B2 (en) * 2015-10-01 2019-08-27 Senomyx, Inc. Compounds useful as modulators of TRPM8
ES2971449T3 (es) * 2017-02-24 2024-06-05 Hisamitsu Pharmaceutical Co Parche cutáneo adhesivo y producto envasado del mismo
TWI825013B (zh) * 2017-04-19 2023-12-11 日商帝國製藥股份有限公司 含有盧帕他定（ｒｕｐａｔａｄｉｎｅ）之貼附劑
CN107375249A (zh) * 2017-07-26 2017-11-24 徐静 一种含罗匹尼罗的缓释透皮贴剂及其应用
US20200297654A1 (en) * 2017-10-17 2020-09-24 Lubrizol Advanced Materials, Inc. Composition and device for delivery of active agents to skin surfaces

Also Published As

Publication number Publication date
KR102577838B1 (ko) 2023-09-12
WO2022091925A1 (ja) 2022-05-05
JP7284877B2 (ja) 2023-05-31
CN116322658B (zh) 2025-09-26
TW202227052A (zh) 2022-07-16
KR20230088789A (ko) 2023-06-20
EP4238563A1 (en) 2023-09-06
EP4238563B1 (en) 2025-09-24
EP4238563A4 (en) 2024-10-02
US20240016758A1 (en) 2024-01-18
US12440452B2 (en) 2025-10-14
TWI821765B (zh) 2023-11-11
JPWO2022091925A1 (enExample) 2022-05-05
CN116322658A (zh) 2023-06-23

Similar Documents

Publication Publication Date Title
IL284324A (en) Aza-heterobicyclic MAT2A inhibitors and methods for use in the treatment of cancer
PL3902803T3 (pl) Aza-heterobicykliczne inhibitory mat2a i sposoby zastosowania do leczenia nowotworu
EP4022679A4 (en) Integrated assemblies, and methods of forming integrated assemblies
IL276365A (en) A method for the production of natural killer cells and a preparation for cancer treatment
EP3889247A4 (en) SKIN PIGMENTATION MODEL AND METHOD FOR PRODUCTION THEREOF, AND FACTOR EVALUATION METHOD FOR TREATMENT OR PREVENTION OF SKIN PIGMENTATION
EP4025317A4 (en) CONDUIT CONTACTOR AND METHOD OF USING THE SAME
GB202314118D0 (en) Methods of classifying and treating patients
GB2614981B (en) Therapeutic cure-pro compounds for targeted degradation of bet domain proteins, and methods of making and using them
ES3049508T3 (en) Ropinirole-containing patch and method for improving skin permeability of ropinirole
EP4422741A4 (en) SYSTEM AND METHOD FOR ELECTRICAL STIMULATION OF TISSUE
EP3982999A4 (en) COMPOSITION AND METHODS OF TREATMENT OF LIVER TISSUE DAMAGE
PL4313576T3 (pl) Urządzenie oraz sposób korygowania kształtu krawędzi rurek
EP4032588A4 (en) Ropinirole-containing patch and method for improving skin permeability of ropinirole
GB2599748B (en) Surfboard and method of construction
IL299082A (en) Methods for identifying and characterizing analviruses and their uses
GB2607584B (en) Composition and method of treatment
EP4418960A4 (en) DISPLAY PANEL AND METHOD OF USING SAME
EP4179334A4 (en) METHODS FOR ASSESSING THE RISK AND TREATMENT OF PREECLAMPSIA AND SUBTYPES THEREOF
EP4337324A4 (en) METHODS FOR THE IDENTIFICATION AND TREATMENT OF SEVERE FORMS OF COVID-19
GB202112482D0 (en) Method and apparatus to determine anisotropy of formation permeability
AU2020904094A0 (en) Polypeptides and methods for improving skin conditions
AU2020904088A0 (en) Polypeptides and methods for improving skin conditions
AU2020902588A0 (en) Polypeptides and methods for improving skin conditions
AU2020901846A0 (en) Polypeptides and methods for improving skin conditions
HK40086357A (en) New use and method of treatment